Key Ingredients:
Availability: In Stock
Estepas-M Tablets: Effective Relief from Abdominal Pain and Cramps
Estepas-M Tablets, brought to you by Esteve Pharma Limited, are a combination medicine designed to provide quick and effective relief from abdominal pain, bloating, discomfort, and cramps. The unique formulation combines Drotaverine and Mefenamic Acid, two powerful ingredients that work together to relax the muscles of the stomach and intestines while blocking the chemical messengers responsible for causing pain and inflammation.
What are Estepas-M Tablets?
Estepas-M Tablets are used in the treatment of various types of abdominal pain, including spasms and cramps in the stomach, intestines, bile ducts, and urinary tract. This medication is particularly helpful in conditions such as biliary colic, renal colic, and post-surgical uterine spasms. By combining the antispasmodic effects of Drotaverine with the pain-relieving properties of Mefenamic Acid, Estepas-M Tablets provide comprehensive relief from abdominal discomfort.
Uses of Estepas-M Tablets
Estepas-M Tablets are used to treat various conditions that cause abdominal pain, spasms, and discomfort, including:
Benefits of Estepas-M Tablets
Conditions Treated by Estepas-M Tablets
How to Take Estepas-M Tablets
Estepas-M Tablets offer an effective solution for individuals suffering from abdominal pain, bloating, cramps, and discomfort. By combining the muscle-relaxing properties of Drotaverine with the pain-relieving effects of Mefenamic Acid, these tablets provide fast and reliable relief from a variety of abdominal conditions.
Whether you are dealing with the pain of biliary or renal colic, post-surgical uterine spasms, or general abdominal discomfort, Estepas-M Tablets can help alleviate your symptoms and improve your quality of life. By following your doctor’s instructions and completing the full course of treatment, you can effectively manage abdominal pain and discomfort, allowing you to get back to your daily routine with ease.
Reviews
There are no reviews yet.